✦ LIBER ✦

463 Clinical and virological characteristics of HBeAg-negative patients with chronic hepatitis B in china from 2000 to 2003

✍ Scribed by J.L. Hou; C.G. Yang; L.C. Yu; J.J. Chen; J. Sun; K.X. Luo; Y.E. Zhu; Y.B. Guo

Book ID: 117374740
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 263 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80463-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcome of HBeAg-negative chron

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

✍ Dr. Vito Di Marco; Alfredo Marzano; Pietro Lampertico; Pietro Andreone; Teresa S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis is unclear. In a retrospective multicenter study, we have analyzed the virological events observed during lamivudine therapy in patients with HBeAgnegative chronic hepatitis an

Optimal duration of additional therapy a

Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial

✍ Masaru Enomoto; Akihiro Tamori; Madoka Toyama Kohmoto; Takehiro Hayashi; Hiroyas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

P.056 Virological and clinical correlate

P.056 Virological and clinical correlates of hepatitis B virus (HBV) DNA levels in patients with HBe-negative, genotype D chronic hepatitis B

✍ S. Chevaliez; G. Germanidis; F. Roudot-Thoraval; M. Bouvier-Alias; F. Guerre; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 144 KB

734 CLINICAL AND VIROLOGICAL FEATURES OF

734 CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS

✍ T. Umemura; K. Kiyosawa; E. Tanaka 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PIN31 COST-EFFECTIVENESS ANALYSIS OF TEL

PIN31 COST-EFFECTIVENESS ANALYSIS OF TELBIVUDINE VS LAMIVUDINE IN TREATING THE PATIENTS WITH HBEAG-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B IN CHINA

✍ Chen, W; Hou, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

484 On-treatment predictors of sustained

484 On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon α-2a (40 kDa) (PEGASYS®)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB